Radius Health Inc., of Cambridge, Mass., closed a second tranche of a three-tranche financing worth $91 million total. The second close includes $21.4 million in equity financing by current investors and $6.25 million in debt financing. Proceeds will fund the ongoing Phase III trial of BA058 for osteoporosis.